Aaron from YMB: CYDY SUING 13D POINTS PT 2: 1) We now

New Post Public Reply Private Reply Replies (3) Message Board
Firelife619
1,369
Aaron from YMB:

CYDY SUING 13D POINTS PT 2:

1) We now have the answers from 13D. As I stated in my last post about the chancery court case, the accusations by Cytodyn against 13D were of a binary yes or no nature.

I will go through some later but basically 1) Are the facts stated by Cytodyn true? 2). Did 13D leave them out of their submission to investors?

The answer is yes and yes. There was no way for 13D counsel to deny it. This has left them with the only possible avenue to explore. While everything asserted is correct, it's not important or out of the hands of Patterson whose company made the decision without him (more on that later).

Many posters have noted these are horrible answers but under the circumstances it was all they had.

2) CASE WAS EXPEDITED.
Generally a case like this gets expedited because the judge has seen the preliminary evidence and believes that the decision is a forgone conclusion. If so, best to not waste the courts time and make a ruling.

Had the 13D response been to refute the facts that may have swayed the judge. But saying the facts are true but insubstantial I don't believe will cut well with this judge

This judge apparently has decades of experience in corporate law decisions and corporate bylaws. She saw something (the binary conclusion I mentioned before) that caused her to expedite the case.

The 13D response is basically, your eyes aren't deceiving you, it's your brain. None of those material facts are important!

I don't think that's going to hold much water.

3) NEXT STEP?

Most likely the next step is the judge is going to now throw the ball back to Sidley for a response/rebuttal to 13D's answer and she will make a judgement from that.

4) PATTERSON TALKS TOO MUCH

For all BP scientific knowledge he doesn't seem to know what most every American citizen knows. When involved in court proceedings, just shut up.

The argument that BP wasn't part of a buyout offer for Incelldx is practically refuted by BP's own tweet. He discusses it openly even mentioning a confidentiality that was broken so he can talk about it implying he was directly a party to the actions (This tweet was only last week SMH).

Cytodyn is suing for an injunction to silence the 13D and there is Patterson saying he is free to openly discuss matters now. He's practically making the case for Cytodyn that he needs to be muzzled.

But wait there is a lot more.

5) DID BP GET PAID FOR ASSAYS?

BP tweeted that he withheld the Assays because he didn't get paid. (I will link to it separately in the reply section so it doesn't pull this main post down).

It's been stated as fact in the Sidley documents submitted to court that BP was eventually getting $20,000 per month for his services. It seems BP felt the Assays were a separate deal

One can surmise where this went off the rails. BP demanding payment for Assays, NP asking what the hell he is paying $20K a month for?

So were the assays supposed to be separately billable?

The Assays would have been months of work. If BP felt he wasn't paid for months of work, one wonders why he didn't sue in court for non-payment of contracted work?

Ask yourself if you would have sued the company after performing months of labor and didn't get paid?

NP certainly has evidence of the monthly$20K arrangements. It looks more and more like BP simply withheld the Assays.

6) BP TIMELINE

A) BP getting paid $20K a month from Cytodyn

B) BP hyped Leronlimab even doing speaking engagements

C) BP tries to sell Incelldx for $350 million to Cytodyn and is rejected.

D) BP gets caught trying to patent Cytodyn tech.

E) BP withholds important Assays that will affect BLA submission.

F) BP doesn't sue for non-payment of Assays work even though he claims he is owed money

G) BP starts playing up Ivermectin and Maraviroc and downplaying Cytodyn.

H) BP signs onboard to 13D proxy battle.

I) BP involvement from the timeline above left out of 13D submission

Now how does this timeline look?

7) BP SP AFFECT

The OWS comments by BP may also be submitted in the Sidley response.

They caused a positive spike in the stock price as well as generating a number of articles. The info was incorrect as well but that's besides the point.

The point will be to show how the stock price jumped just on the single comments of BP.

Why is this pertinent? Cytodyn is claiming the 13D and BP need an injunction because they are affecting the SP. BP's OWS comments and the resultant SP spike go towards proof his words matter and the need for the injunction.

CONCLUSION:. None of this looks good for 13D. As this is simply to decide if an injunction is warranted I don't see this court battle taking too long to conclude.

BP saying he can talk about confidential agreement pertaining to sale of Incelldx

https://mobile.twitter.com/brucep13/status/14...0750248967

BP tweeting he withheld Assays

https://mobile.twitter.com/brucep13/status/14...0942012417
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Northwood's $375M Boost: Satellite Network Expansion

Updated Category News Views 129

Northwood's Bold Leap into Space Connectivity Here's a nugget of info that could jolt your morning coffee: Northwood Space Corp—yeah, the folks linking satellites to Earth—just pulled in a whopping $375 million in Series C funding. This ain't your average capital injection; it's a full-throttle push to broaden their ground network reach and revamp space...

Continue Reading
Rana Gillmon Takes on Bigger Role at AXA XL

Updated Category News Views 42

Leadership Leap for Rana Gillmon Well, we've got some buzz from AXA XL that's stirring the pot in the insurance scene, with Rana Gillmon taking on a more expansive role. She's now at the helm of client and distribution activities in the East Zone of the U.S. alongside her existing responsibilities in private equity client relations across the Americas. Sounds like a hefty...

Continue Reading
Helsinki's Christmas Market: Saunas and Sustainability

Updated Category News Views 49

Finnish Heat at a Christmas Market? It's not every day you hear about donning a swimsuit in freezing Helsinki. But this Christmas, that's exactly what's happening in their market. A classic Finnish sauna is set to take center stage, blending the chill of the festive season with legendary heat—a quirky mix that might just be the next big draw for tourists. A Different...

Continue Reading
Michael Schade Joins LIU as VP and General Counsel

Updated Category News Views 62

Shaping the Future with a Legal Vet Michael Schade slipping into the VP and General Counsel chair at Long Island University isn't just another nameplate shuffle. It's a solid move for a university looking to tighten its grip on being a major research player. A Power Player from the University of Oklahoma Schade isn't new to the world of academic law. He's packing legal...

Continue Reading
Alamo Group Eyes Growth Amidst Margin Headwinds

Updated Category News Views 14

Challenging Times Meet Strategic Moves On the face of it, Alamo Group's (NYSE: ALG) third-quarter results for 2026 paint a mixed picture. Sales dipped by 4% compared to the same quarter last year, settling at $403.1 million. No investor likes to see a decline, that's for sure. Yet, peeling back a few layers, there's more to the story than just the raw numbers. Let's chew...

Continue Reading
ACA 2027 Enrollment: New Rules Aim to Simplify Coverage

Updated Category News Views 39

Navigating New Waters in 2027 ACA Open Enrollment If you're one of those folks who likes to wait until the last minute, the ACA's got a wake-up call for you this year. The 2027 open enrollment period started on November 1, 2026, with some pretty notable changes. The deadline for coverage beginning January 1, 2027, is December 15, so don't take a nap on this one, alright?...

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 62

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
PRA Group Marks 30 Years with Nasdaq Bell Ringing

Updated Category News Views 61

A Milestone in Times Square Thirty trips around the sun, and here we are: PRA Group, the change-maker in the world of nonperforming loans, is celebrating by ringing the Nasdaq Opening Bell. It's a pretty big to-do in the financial world to get this nod, standing out in New York City's Times Square, no less. This shindig showcased Martin Sjolund, their President and CEO,...

Continue Reading
Julie Boland's Strategic Move to Deere's Board

Updated Category News Views 63

Deere & Company Expands Leadership with Boland Out of the blue, Deer & Company (NYSE: DE) decided to shake things up by adding Julie Boland, the former U.S. honcho at Ernst & Young LLP, to their board. Now, when Deere gets a leader with her pedigree, there’s more than a whiff of strategy at play. Let’s unpack why Deere's pulling the trigger on this boardroom shift....

Continue Reading
Allegiant Overhauls Service with UNLV Training

Updated Category News Views 64

Allegiant Airlines and UNLV: A Unique Collaboration The world of airline customer service is about to get a shakeup, thanks to a new collaboration between Allegiant Airlines and the University of Nevada, Las Vegas' renowned William F. Harrah College of Hospitality. It's a partnership that aims to bring a new level of service to the skies, guided by some of the best minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Leap Partners' Latest Acquisition Strengthens HVAC Presence

Updated Category News Views 271

Leap Partners Expands HVAC Operations with New Acquisition Leap Partners is excited to announce its latest expansion through the acquisition of Air Control Heating and Air Conditioning, a well-respected HVAC provider known for its excellent customer service. This acquisition marks a significant milestone as Leap Partners continues to solidify its presence across the...

Continue Reading
Niu Technologies Set to Share Q3 2025 Financial Insights Soon

Updated Category News Views 197

Niu Technologies Prepares for Third Quarter Financial Results Niu Technologies (NASDAQ: NIU), a leader in smart urban mobility solutions, is gearing up to report its financial data for the third quarter of 2025. This report will be released prior to the U.S. market opening on an upcoming Monday. Details of the Financial Results Release Investors and stakeholders can...

Continue Reading
Optical Cable Corporation's Q3 2024 Results Show Strategic Growth

Updated Category News Views 60

Optical Cable Corporation Releases Third Quarter Financial Results Optical Cable Corporation (NASDAQ: OCC) has recently shared its financial performance for the third quarter of the fiscal year 2024. Despite encountering some difficulties in the market, the company provided valuable insights into its operational outcomes and future expectations. Overview of Financial...

Continue Reading
Espey Mfg. & Electronics Corp. Declares Special Dividend Announcement

Updated Category News Views 98

Exciting Dividend Announcements from Espey Mfg. & Electronics Corp. Espey Mfg. & Electronics Corp. (NYSE AMERICAN: ESP) has made a significant announcement that is sure to catch the attention of its investors and shareholders alike. The company’s Board of Directors has declared a special cash dividend of $0.75 per share. This exciting news comes in addition to the...

Continue Reading
Key Economic Indicators to Watch This Week for Insights

Updated Category News Views 68

Understanding Key Economic Indicators on Wednesday As traders gear up for another critical day in financial markets, a series of significant economic data releases are set to take place, capturing the interest and focus of investors and analysts alike. Notably, the upcoming day features the ADP Nonfarm Employment Change and the EIA Crude Oil Inventories, both of which...

Continue Reading